he overall theme is to discuss how to regenerate tissues/organs to optimally integrate with the host. The goal is to bring together clinicians, scientists, and engineers to explore new ideas and catalyze new collaborations to address key barriers to the translation of regenerative medicine technologies. ARMI’s Chief Regulatory Officer, Dr. Richard McFarland, will present Views from the bridge over the ‘valley of death’: Thoughts on how to turn great ideas into usable medical products.
Format: Short talks identifying clinical problems and emerging technologies, followed by breakout sessions to identify opportunities
